spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Pharmaceutical Microbiology East Coast

SMI - Pharmaceutical Microbiology East Coast

13-14 November 2017
Renaissance Woodbridge Hotel, New Jersey

Drawing on from the huge success of SMi’s Pharmaceutical Microbiology event series, SMi is delighted to announce the launch of Pharmaceutical Microbiology East Coast. Being the eighth in its series, this event will take place in New Jersey, USA, on November 13th and 14th 2017. Aimed at Microbiologists, Quality Control and Quality Assurance Managers, Pharmaceutical Microbiology East Coast 2017 will address the best practices for rapid microbial and sterility testing and tackle the challenges of contamination control.

Pharmaceutical Microbiology East Coast has been produced with a vision of promoting the field of microbiology, and has been tailored to address the current issues and opportunities the industry faces every day. Topics of interest will include:
• The role of microbiology in pharmaceutical stability programs
• Deciphering the host-microbe interaction
• Benefits of real-time monitoring of airborne viable microorganisms
• Current expectations for a complete environmental monitoring program
• Quality control strategy on low endotoxin recovery (LER)
• Implementation of a global electronic intervention logging system
Chair for 2017:
• Jeanne Moldenhauer, Vice President, Excellent Pharma Consultant
Expert Speaker Line-Up Includes:
• Andrew Bartko, Research Leader, Battelle Memorial Institute
• Brian Hubka, CEO, BGH Internationalv
• Shawn Sweeney, Senior Process Development Manager, Charles River
• Frederic Ayers, Consultant Scientist, Sterility Assurance, Eli Lilly And Company
• Geeta Singh, Pilot Plant Technical Specialist III, Genentech
• Somduttan Saha, Post-Doctoral Scientist, Glaxosmithkline
• Shahram Lavasani, CEO, ImmuneBiotech AB
• James Hauschild, Principal Scientist, Johnson & Johnson
• Tony Cundell, Principal Consultant, Microbiological Consulting, LLC
• David Huang, Chief Medical Officer, Motif BioSciences
• Tony Van Hoose, Director, Sterile Technologies Expertise, Sanofi
• Jim Polarine, Senior Technical Service Manager, STERIS Corporation
• Joseph Chen, Executive Director, CMC Quality Control, Ultragenyx Pharmaceutical
Exclusive highlights in 2017:

• Discuss training of media fill inspection operators with Sanofi
• Decipher the Host-Microbe interaction with GlaxoSmithKline
• Hear Eli Lilly’s keynote address on Implementation of a global electronic intervention logging system
• Understand the role of microbiology in pharmaceutical stability programs with Microbiological Consulting, LLC
• Delve into the current expectations for a complete environmental monitoring program with Excellent Pharma Consulting
Other event highlights include TWO exclusive post-conference interactive workshops carefully selected to enhance your conference experience and encourage personal and professional development. Places are strictly limited to ensure optimal learning for attendees.

Workshop A – Navigating the requirements of a modern QC Microbiology Laboratory
Wednesday 15th November 2017 | 08.30 – 12.30
Workshop Leaders: Quality Executive Partners, Inc.

Workshop B – Contamination Control in Cleanrooms
Wednesday 15th November 2017 | 13.30 – 17.30
Workshop Leader: STERIS Corporation
phone Tel: +44 (0) 207 827 6012
email kwilliams@smi-online.co.uk
web bit.ly/2snC3tc
email New Jersey, USA
 
Print this page
Send to a friend
   
spacer
Industry Events

8th Clinical Quality Oversight Forum 2017

11-13 October 2017, Sheraton Philadelphia Downtown Hotel, Philadelphia, PA

ExL’s Clinical Quality Oversight Forum continues to live up to its reputation as an elite gathering of senior-level executives.
More info >>

White Papers

Unmet Medical Needs? Impacted by unmet Life Sciences Staffing Needs?

Clinical Professionals

Whilst the majority of Clinical Professionals clients are working to discover and develop innovative, cost effective medicines that address unmet medical needs they are not impacting the unmet needs of training and developing new recruits into the pharma industry. The impact is highlighted within entry level Clinical Trial Administrators and Clinical Research Associates (CTA/CRA). In the past the Pharmaceutical industry had highly developed training programs for these sought after candidates. As the use of outsourcing models and CRO’s has increased and fewer Pharma businesses embark on their own R&D a substantial gap is developing in newly trained Life Science graduates entering the market to commence a career within R&D. As further financial cuts are made within R&D spend this already dire situation continues to escalate.
More info >>


News and Press Releases

NDA GROUP EXPANDS SERVICE OFFERINGS AND GEOGRAPHIC REACH APPOINTING NEW US SERVICE AREA LEADERS AND HEAD OF BUSINESS DEVELOPMENT


More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement